Search

everythinglearnresearchcommunity

for

Search:↓

Gilles de la Tourette syndrome is treatable, with behavioral therapy as a recommended first option and other treatments available for more severe cases.

Get head MRI for babies with achondroplasia early, use free immunoglobulin light chains to detect certain neurodevelopmental disorders, and video calls work for speech therapy in patients with facial anomalies.

More research is needed to confirm the potential of various treatments, including Helichrysum plicatum, vitamins, bromelain, personalized medications, hydrogels, and bacteriophage therapy.

Light therapy on the brain shows promise for treating brain diseases and improving brain function.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

Trichotillomania involves hair pulling and can be treated with therapy and medication.

Monosaccharide composition in plant polysaccharides significantly affects their biological activities and therapeutic potential.

Natural plant products like Proanthocyanidins and curcumin may help treat ischemic stroke by reducing inflammation.

Stem cells from elderly skin can become neurons, offering potential for brain therapy.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

THAP1 gene changes do not affect DYT1 dystonia; finasteride may help reduce tics and OCD in Tourette syndrome.

A specific gene mutation is linked to a hereditary form of dystonia that responds well to certain medications.

Finasteride significantly reduced tics and obsessive-compulsive symptoms in Tourette syndrome patients.

Finasteride may help reduce tic severity in male Tourette syndrome patients.

Conditioned media from mesenchymal stem cell cultures could be a more effective alternative for regenerative therapies, but more research is needed.

Stem cells help repair tissue mainly by releasing beneficial substances, not by replacing damaged cells.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Extended-release valproate effectively reduced seizures and improved quality of life in epilepsy patients over 6 months, with some side effects.

Levodopa for Parkinson's disease might be linked to skin issues like melanoma, but it's unclear if the drug or the disease causes them.

NDP-MSH protects brain cells and reduces inflammation in Parkinson's disease by activating MC1R and involving Tregs.

Stem cells show promise for hair regrowth, but challenges remain.

Women with polycystic ovary syndrome (PCOS) show higher levels of hope, judgement, perspective, and transcendence, and could benefit from positive psychology therapy.

Antioxidants may help improve mitochondrial health and could be used to treat diseases related to cell damage.

Oestrogen and thyrotropin-releasing hormone affect prolactin and its receptor in human skin and hair, suggesting new treatment options for related conditions.

Polygonum multiflorum shows promise for treating Alzheimer's and cognitive impairments.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

The document describes a woman with familial Parkinson's disease due to a genetic mutation, showing severe symptoms and poor response to treatment, and suggests finasteride may help reduce symptoms in Tourette syndrome.

Some medicinal plants can help heal wounds and may lead to new treatments.